TY - JOUR
T1 - Study on the Prevention of Allergy in Children in Europe (SPACE)
T2 - Allergic sensitization in children at 1 year of age in a controlled trial of allergen avoidance from birth
AU - Halmerbauer, Gerhard
AU - Gartner, Christian
AU - Schierl, Michael
AU - Arshad, Hassan
AU - Dean, Tara
AU - Koller, Dieter Y.
AU - Karmaus, Wilfried
AU - Kuehr, Joachim
AU - Forster, Johannes
AU - Urbanek, Radvan
AU - Frischer, Thomas
PY - 2002
Y1 - 2002
N2 - Several studies have demonstrated that early intervention may modulate the natural course of atopic disease. Our objective was to prevent sensitization to house-dust mite and food allergens, as well as the development of atopic symptoms during infancy, by the combination of an educational package and the use of mite allergen-impermeable mattress encasings. A multicentre European, population-based, randomized, controlled study of children at increased atopic risk [Study on the Prevention of Allergy in Children in Europe (SPACE)] was performed in five countries (Austria, Germany, Greece, the UK, and Lithuania), and included three cohorts - schoolchildren, toddlers, and newborns. We report on the newborn cohort. A total of 696 newborns were included from Austria, the UK, and Germany. Inclusion criteria were: a positive history of parental allergy; and a positive skin-prick test or specific immunoglobulin E (IgE) (IgE ≥ 1.43 kU/L) against at least one out of a panel of common aeroallergens in one or both parents. At 1 year of age, the overall sensitization rate against the tested allergens [dust-mite allergens: Dermatophagoides pteronyssinus and Dermatophagoides farinae (Der p and Der f)] and food allergens (egg, milk) in the prophylactic group was 6.21% vs. 10.67% in the control group. The prevalence of sensitization against Derp was 1.86% in the prophylactic group vs. 5% in the control group. In conclusion, we were able to demonstrate, in a group of newborns at risk for atopic diseases, that the sensitization rate to a panel of aero- and food allergens could be effectively decreased through the use of impermeable mattress encasings and the implementation of easy-to-perform preventive measures.
AB - Several studies have demonstrated that early intervention may modulate the natural course of atopic disease. Our objective was to prevent sensitization to house-dust mite and food allergens, as well as the development of atopic symptoms during infancy, by the combination of an educational package and the use of mite allergen-impermeable mattress encasings. A multicentre European, population-based, randomized, controlled study of children at increased atopic risk [Study on the Prevention of Allergy in Children in Europe (SPACE)] was performed in five countries (Austria, Germany, Greece, the UK, and Lithuania), and included three cohorts - schoolchildren, toddlers, and newborns. We report on the newborn cohort. A total of 696 newborns were included from Austria, the UK, and Germany. Inclusion criteria were: a positive history of parental allergy; and a positive skin-prick test or specific immunoglobulin E (IgE) (IgE ≥ 1.43 kU/L) against at least one out of a panel of common aeroallergens in one or both parents. At 1 year of age, the overall sensitization rate against the tested allergens [dust-mite allergens: Dermatophagoides pteronyssinus and Dermatophagoides farinae (Der p and Der f)] and food allergens (egg, milk) in the prophylactic group was 6.21% vs. 10.67% in the control group. The prevalence of sensitization against Derp was 1.86% in the prophylactic group vs. 5% in the control group. In conclusion, we were able to demonstrate, in a group of newborns at risk for atopic diseases, that the sensitization rate to a panel of aero- and food allergens could be effectively decreased through the use of impermeable mattress encasings and the implementation of easy-to-perform preventive measures.
KW - Allergy
KW - Derp
KW - Dust mites
KW - Newborns
KW - Prevention
KW - Sensitization
KW - Floors and Floorcoverings
KW - Immunization
KW - Prospective Studies
KW - Follow-Up Studies
KW - Risk Reduction Behavior
KW - Humans
KW - Hypersensitivity, Immediate/epidemiology
KW - Incidence
KW - Europe/epidemiology
KW - Allergens/adverse effects
KW - Antigens, Dermatophagoides/adverse effects
KW - Immunoglobulin E/blood
KW - Infant Welfare
KW - Surveys and Questionnaires
KW - Infant, Newborn
KW - Antibody Specificity/immunology
UR - http://www.scopus.com/inward/record.url?scp=12244307467&partnerID=8YFLogxK
U2 - 10.1034/j.1399-3038.13.s.15.11.x
DO - 10.1034/j.1399-3038.13.s.15.11.x
M3 - Article
C2 - 12688625
AN - SCOPUS:12244307467
SN - 0906-5784
VL - 13
SP - 47
EP - 54
JO - Pediatric Allergy and Immunology, Supplement
JF - Pediatric Allergy and Immunology, Supplement
IS - 15
ER -